Najoua Lalaoui

Dikutip oleh

	Semua	Sejak 2020
Kutipan	6814	3916
indeks-h	34	29
indeks-i10	39	37

880

440

220

660

200720082009201020112012201320142015201620172018201920202021202220232024202523 39 55 59 91 90 125 195 282 372 439 499 598 704 872 757 687 749 145

Akses publik

Lihat semua

39 artikel

1 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

John SilkeProfessor, The Walter and Eliza Hall InstituteEmail yang diverifikasi di latrobe.edu.au
olivier micheauResearch Director, INSERM, Université de BourgogneEmail yang diverifikasi di u-bourgogne.fr
Delphine MerinoOlivia Newton-John Cancer Research InstituteEmail yang diverifikasi di onjcri.org.au
David L VauxDeputy Director, The Walter and Eliza Hall InstituteEmail yang diverifikasi di wehi.edu.au
Andreas StrasserThe Walter and Eliza Hall InstituteEmail yang diverifikasi di wehi.edu.au
Silvia Alvarez-DiazPostdoctoral Fellow at Walter and Eliza Hall Institute of Medical ResearchEmail yang diverifikasi di wehi.edu.au
Andrew I. WebbAssociate Professor - The Walter and Eliza Hall InstituteEmail yang diverifikasi di wehi.edu.au
Gordon K SmythDivision Head, Bioinformatics, Walter and Eliza Hall Institute of Medical ResearchEmail yang diverifikasi di wehi.edu.au
Nima EtemadiThe Walter and Eliza Hall Institute of Medical researchEmail yang diverifikasi di wehi.edu.au
W. Wei-Lynn WongGroup Leader, Dept of Molecular Life SciencesEmail yang diverifikasi di uzh.ch
Nicos A NicolaDivision Head, Walter and Eliza Hall InstituteEmail yang diverifikasi di wehi.edu.au
Jian-Guo ZhangSenior Research Scientist, The Walter and Eliza Hall Institute of Medical Research, MelbourneEmail yang diverifikasi di wehi.edu.au
Renwick CJ DobsonProfessor of Chemical Biology, School of Biological Sciences, University of CanterburyEmail yang diverifikasi di canterbury.ac.nz
jeff babonwalter and eliza hall instituteEmail yang diverifikasi di wehi.edu.au
Andrew H. WeiPeter MacCallum Cancer Centre, Royal Melbourne Hospital and Walter and Eliza Hall Institute ofEmail yang diverifikasi di petermac.org
William J. KaiserUniversity of Texas Health Science CenterEmail yang diverifikasi di uthscsa.edu
Lisa LindqvistCSL LtdEmail yang diverifikasi di csl.com.au
francois virardMCU-PH, faculté d'odontologie de LyonEmail yang diverifikasi di lyon.unicancer.fr
Guy SalvesenProfessor, Sanford-Burnham Medical Research InstituteEmail yang diverifikasi di sbpdiscovery.org
Arnaud JacquelInserm U1065, C3M, Nice, FranceEmail yang diverifikasi di unice.fr

Ikuti

Najoua Lalaoui

Group Leader, Peter MacCallum Cancer Center

Email yang diverifikasi di petermac.org - Beranda

Apoptosis Necroptosis Cancer inflammation


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism JM Murphy, PE Czabotar, JM Hildebrand, IS Lucet, JG Zhang, ... Immunity 39 (3), 443-453, 2013	1268	2013
RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis JA Rickard, JA O’Donnell, JM Evans, N Lalaoui, AR Poh, TW Rogers, ... Cell 157 (5), 1175-1188, 2014	622	2014
Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2 D Mérino, N Lalaoui, A Morizot, P Schneider, E Solary, O Micheau Molecular and cellular biology 26 (19), 7046-7055, 2006	415	2006
Tumor immune evasion arises through loss of TNF sensitivity CJ Kearney, SJ Vervoort, SJ Hogg, KM Ramsbottom, AJ Freeman, ... Science immunology 3 (23), eaar3451, 2018	340	2018
MK2 phosphorylates RIPK1 to prevent TNF-induced cell death I Jaco, A Annibaldi, N Lalaoui, R Wilson, T Tenev, L Laurien, C Kim, ... Molecular cell 66 (5), 698-710. e5, 2017	295	2017
MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis AL Samson, Y Zhang, ND Geoghegan, XJ Gavin, KA Davies, ... Nature communications 11 (1), 3151, 2020	288	2020
Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease N Lalaoui, SE Boyden, H Oda, GM Wood, DL Stone, D Chau, L Liu, ... Nature 577 (7788), 103-108, 2020	275	2020
TNFR1-dependent cell death drives inflammation in Sharpin-deficient mice JA Rickard, H Anderton, N Etemadi, U Nachbur, M Darding, N Peltzer, ... Elife 3, e03464, 2014	271	2014
The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis S Alvarez-Diaz, CP Dillon, N Lalaoui, MC Tanzer, DA Rodriguez, A Lin, ... Immunity 45 (3), 513-526, 2016	228	2016
The molecular relationships between apoptosis, autophagy and necroptosis N Lalaoui, LM Lindqvist, JJ Sandow, PG Ekert Seminars in cell & developmental biology 39, 63-69, 2015	227	2015
TRAIL in cancer therapy: present and future challenges D Mérino, N Lalaoui, A Morizot, E Solary, O Micheau Expert opinion on therapeutic targets 11 (10), 1299-1314, 2007	209	2007
Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer D Merino, JR Whittle, F Vaillant, A Serrano, JN Gong, G Giner, ... Science translational medicine 9 (401), eaam7049, 2017	200	2017
dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8 Y Estornes, F Toscano, F Virard, G Jacquemin, A Pierrot, B Vanbervliet, ... Cell Death & Differentiation 19 (9), 1482-1494, 2012	193	2012
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia G Brumatti, C Ma, N Lalaoui, NY Nguyen, M Navarro, MC Tanzer, ... Science translational medicine 8 (339), 339ra69-339ra69, 2016	180	2016
cIAPs and XIAP regulate myelopoiesis through cytokine production in an RIPK1-and RIPK3-dependent manner WWL Wong, JE Vince, N Lalaoui, KE Lawlor, D Chau, A Bankovacki, ... Blood, The Journal of the American Society of Hematology 123 (16), 2562-2572, 2014	179	2014
The TNF receptor superfamily-NF-κB axis is critical to maintain effector regulatory T cells in lymphoid and non-lymphoid tissues A Vasanthakumar, Y Liao, P Teh, MF Pascutti, AE Oja, AL Garnham, ... Cell reports 20 (12), 2906-2920, 2017	141	2017
Targeting p38 or MK2 enhances the anti-leukemic activity of Smac-mimetics N Lalaoui, K Hänggi, G Brumatti, D Chau, NYN Nguyen, L Vasilikos, ... Cancer cell 29 (2), 145-158, 2016	125	2016
Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions S Monnier-Benoit, V Dalstein, D Riethmuller, N Lalaoui, C Mougin, ... Journal of clinical virology 35 (3), 270-277, 2006	117	2006
Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level A Morizot, D Mérino, N Lalaoui, G Jacquemin, V Granci, E Iessi, ... Cell Death & Differentiation 18 (4), 700-711, 2011	106	2011
TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT N Lalaoui, A Morlé, D Mérino, G Jacquemin, E Iessi, A Morizot, S Shirley, ... PloS one 6 (5), e19679, 2011	103	2011

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama